FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to experimental oncology and mammalogy, and can be used as a model of cystic fibrosis of breast cancer. Method involves intramuscular introduction for virgin female rats a synestrol in a dose of 0.5 ml of 2 % oil solution in combination with 0.5 ml of 2.5 % progesterone oil solution. Introduction is performed in 1, 7, 14, 21, 28 and 35 days of experiment.
EFFECT: method ensures production of morphological changes of mammary gland, similar to those changes in females, that enables a detailed studying the pathogenesis of the disease and facilitate development of paths of primary prevention of breast cancer.
1 cl, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR STIMULATING REGRESSION OF CYSTIC PROCESSES IN MAMMARY GLAND UNDER EXPERIMENTAL CONDITIONS | 2004 |
|
RU2270705C2 |
METHOD FOR MODELING MAMMARY FIBROADENOMATOSIS IN EXPERIMENT | 2002 |
|
RU2234740C2 |
METHOD OF MODELING N-NITROSO-N-METHYLUREA-INDUCED BREAST CANCER IN RATS AGAINST THE BACKGROUND OF CHRONIC HYPERESTROGENEMIA | 2022 |
|
RU2798037C1 |
METHOD OF EXPERIMENTAL GYNECOMASTIA MODELLING | 2006 |
|
RU2330327C1 |
METHOD FOR MODELING PRO-CARCINOGENIC EFFECT OF SYNOESTROL ON THE OVARIES OF THE FEMALE OFFSPRING OF LABORATORY MICE | 2018 |
|
RU2676437C1 |
METHOD OF TREATING FIBROCYSTIC DISEASE IN GYNAECOLOGIC PATIENTS | 2009 |
|
RU2405598C2 |
MILK-WAX WALNUT AND BUCKEYE OINTMENT | 2011 |
|
RU2448683C1 |
BREAST CYST FORMATIONS CLASSIFICATION | 2017 |
|
RU2639804C1 |
METHOD FOR DETERMINING EFFECTIVENESS OF DOSE OF DIETARY SUPPLEMENT LIGNARIUS IN PATIENTS WITH FIBROCYSTIC MASTOPATHY | 2022 |
|
RU2806529C1 |
METHOD FOR EXPRESS DIAGNOSTICS OF BREAST DISEASES | 2016 |
|
RU2620159C1 |
Authors
Dates
2016-12-27—Published
2015-12-08—Filed